We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
A consultation is currently being held by the UK Intellectual Property Office (UKIPO) on the scope of the so-called "Bolar exemption" to patent infringement and the impact of the current UK legislation on the conduct of clinical and field trials on pharmaceuticals
